Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 2
1(16.7%)
6Total
N/A(5)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05737472Not ApplicableCompleted

High-protein Quantity and Quality RUTF in Improving Linear Growth Among Children With Severe Wasting

Role: collaborator

NCT01889329Phase 2Completed

Development and Field Testing of Ready-to-use-therapeutic Foods Made of Local Ingredients in Bangladesh for SAM Children

Role: collaborator

NCT02716935Not ApplicableCompleted

Prebiotics and Microbiota Composition and Functionality in Rural Burkinabe Infants

Role: collaborator

NCT03196622Not ApplicableUnknown

Validation of a Screening Test for Sarcopenia in Older People

Role: collaborator

NCT00944853Not ApplicableCompleted

Effects of Liquid Zinc Supplementation and Dispersible Zinc Tablets on Plasma Zinc Concentration

Role: collaborator

NCT01147198Not ApplicableCompleted

Ready to Use Supplementary Food in Moderate Childhood Malnutrition

Role: collaborator

All 6 trials loaded